Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Purdue Pharma LP

www.purduepharma.com

Latest From Purdue Pharma LP

Asia Deal Watch: Takeda Licenses Curadev STING Agonist To Further Its IO Ambitions

The Japanese pharma, continuing to bolster its pipeline after buying Shire, is partnering with Skyhawk in neurodegenerative diseases under another new deal. Also, Purdue cites shifting business priorities for a decision to end Eisai collaboration on sleep disorder drug.

Deals Commercial

US FDA Converges With Other Regulators On Insomnia Drug Warnings, But Broader Safety Disagreements Persist

US FDA will add boxed warnings to insomnia drugs, bringing it in line with other regulators, even as a study in JAMA Internal Medicine study indicates that national drug authorities often disagree more broadly over when to issue safety advisories.
Drug Safety FDA

Two US OxyContin Patents Are Found To Be Invalid

Prior-art references render two US formulation patents protecting OxyContin unpatentable as obvious, a Court of Appeals has confirmed.


Intellectual Property United States

Bill Requiring Justification For Rx Price Hikes Clears House Cmte.

House Ways & Means Committee clears legislation requiring manufacturers to justify 10% WAC increase in one year and 25% increase over three years, and to report number of free product samples.

Legislation Pricing Debate
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Nutraceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Inflammation
  • Neurology, Nervous System
  • Alias(es)
  • Purdue Frederick Co.-Purdue Pharma LP
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Purdue Pharma LP
  • Senior Management
  • Craig Landau, Pres. & CEO
    Jean-Jacques Charhon, CFO
    Saeed Motahari, SVP, Chief Commercial Officer
    Alan Dunton, MD, Head, R&D
    Marcelo Bigal, MD, PhD, CMO
  • Contact Info
  • Purdue Pharma LP
    Phone: (203) 588-8000
    201 Tresser Blvd.
    Stamford, CT 06901
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register